Literature DB >> 8910368

Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.

L Zeng1, S An, E J Goetzl.   

Abstract

The expression by T lymphocytes (T cells) of more than one of the functionally distinct subtypes of prostaglandin E2 (PGE2) receptors (Rs), designated EP1, EP2, EP3, and EP4 Rs, is a principal determinant of specificity and diversity of the immune effects of PGE2. The cultured line of human leukemic T cells, termed HSB.2, co-expresses a total of 7282 +/- 1805 EP3, EP4, and EP2 Rs per cell with a Kd of 3.7 +/- 1.4 nM (mean +/- S.E., n = 9). The EP3/EP1 R-selective agonist sulprostone, EP3/EP2/EP4 R-selective agonists M&B 28767 and misoprostol, and EP2 R-selective agonist butaprost but not the EP1 R-selective antagonist SC-19220 competitively inhibited the binding of [3H]PGE2 to HSB.2 cells. Stimulation of increases in the intracellular concentration of cyclic AMP ([cAMP]i) by PGE2, misoprostol, and butaprost and of increases in the intracellular concentration of calcium ([Ca2+]i) by PGE2 and sulprostone demonstrated the respective involvement of EP2/EP4 Rs and EP3 Rs in transduction of biochemical signals. Matrix metalloproteinase (MMP)-9 was identified by zymography and Western blots as the principal MMP secreted by HSB.2 cells. The cytosolic level and secretion of MMP-9 were increased maximally after 24 h of incubation of HSB.2 cells with 10(-8)-10(-6) M PGE2, sulprostone, M&B 28767, and misoprostol but not with 10(-6) M PGF2alpha, PGD2, PGI2, or butaprost, suggesting a principal dependence on EP3 Rs. That stimulation of MMP-9 secretion by PGE2 was not diminished in Ca2+-free medium but was suppressed significantly and dose-dependently by thapsigargin, an inhibitor of endomembrane Ca2+-ATPase, suggested that MMP-9 expression by HSB.2 cells is mediated by increases in [Ca2+]i attributable to release of Ca2+ from intracellular stores. The lack of effect of dibutyryl cAMP, forskolin, and SQ 22536, an adenylyl cyclase inhibitor, on MMP-9 secretion by HSB.2 cells argued against any role for cAMP-dependent mechanisms linked to EP2/EP4 Rs. Cycloheximide and actinomycin D, which respectively inhibited protein and RNA synthesis, suppressed basal and PGE2 induction of MMP-9 production by HSB.2 cells. Northern analysis indicated that PGE2 and sulprostone time-dependently increased expression of MMP-9 mRNA. Thus, stimulation of MMP-9 in HSB.2 T cells by PGE2 is attributable to [Ca2+]i-dependent EP3 R-mediation of increases in message transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910368     DOI: 10.1074/jbc.271.44.27744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1.

Authors:  E J Thompson; A Gupta; G A Vielhauer; J W Regan; G T Bowden
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

2.  Prostaglandin E2 mediates growth arrest in NFS-60 cells by down-regulating interleukin-6 receptor expression.

Authors:  Kumudika I de Silva; Asif N Daud; JiangPing Deng; Stephen B Jones; Richard L Gamelli; Ravi Shankar
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts.

Authors:  Hideo Inoue; Makiko Takamori; Yoshihito Shimoyama; Hideaki Ishibashi; Seizo Yamamoto; Yasuko Koshihara
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

4.  Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells.

Authors:  Ewa Zaczynska; Bichoy H Gabra; Pierre Sirois
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

5.  EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation.

Authors:  Davelene D Israel; John W Regan
Journal:  Biochim Biophys Acta       Date:  2009-02-06

6.  Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B.

Authors:  Natalia V Gounko; Erik Martens; Ghislain Opdenakker; Vasily Rybakin
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.